AVAH logo

AVAH
Aveanna Healthcare Holdings Inc

404
Mkt Cap
$1.67B
Volume
545,912.00
52W High
$10.32
52W Low
$3.73
PE Ratio
6.51
AVAH Fundamentals
Price
$7.34
Prev Close
$7.67
Open
$7.65
50D MA
$6.74
Beta
1.50
Avg. Volume
1.14M
EPS (Annual)
$1.05
P/B
6.95
Rev/Employee
$68,540.82
$3,058.28
Loading...
Loading...
News
all
press releases
Compared to Estimates, Aveanna (AVAH) Q1 Earnings: A Look at Key Metrics
The headline numbers for Aveanna (AVAH) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
News Placeholder
More News
News Placeholder
Aveanna Healthcare (AVAH) Tops Q1 Earnings and Revenue Estimates
Aveanna (AVAH) delivered earnings and revenue surprises of +35.85% and +5.11%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Encompass Health to Expand Idaho Presence With New 50-Bed Facility
EHC plans a new 50-bed inpatient rehab hospital in Post Falls, expanding its footprint in an underserved market with an expected 2028 opening.
News Placeholder
Unlocking Q1 Potential of Aveanna (AVAH): Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of Aveanna (AVAH) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
News Placeholder
Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
News Placeholder
The Pennant Group, Inc. (PNTG) Q1 Earnings and Revenues Surpass Estimates
The Pennant Group (PNTG) delivered earnings and revenue surprises of +4.92% and +2.42%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Can Execution and Volume Trends Support DaVita's Q1 Earnings?
DVA's first-quarter 2026 results may face seasonal volume and RPT headwinds, but cost discipline, reimbursement growth and IKC contributions could aid results.
News Placeholder
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Consensus Rating of "Moderate Buy" from Brokerages
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) has been given a consensus rating of "Moderate Buy" by the eleven brokerages that are covering the company, Marketbeat Ratings...
News Placeholder
Chemed (CHE) Beats Q1 Earnings and Revenue Estimates
Chemed (CHE) delivered earnings and revenue surprises of +9.28% and +2.59%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Auna S.A.'s Oncology Initiatives Continue to Gain Traction in Mexico
AUNA advances oncology push in Mexico with new Oncocenter, insurer tie-ups, and rising revenues, signaling strong traction in a key growth market.
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available